Concepedia

Khalid Benbatoul

KB

10

Publications

601

Citations

10

H-Index

1998

Active since

Affiliations

University of California San Diego(Current)

Maxygen (United States)

Ligand Pharmaceuticals (United States)

Khalid Benbatoul is an author at University of California San Diego specializing in medicine, cancer research, and tumor biology.

Top concepts

Publications per year

1998–2018

10

Publications

10

Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.

Michael Newman, Jennifer C. Rodarte, Khalid Benbatoul et al. · PubMed · 2000 · 191 citations

, , +21

APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells

Andrea Local, Hongying Zhang, Khalid Benbatoul et al. · Molecular Cancer Therapeutics · 2018 · 83 citations · Full text

Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein–protein interaction profile

Jeffrey N. Miner, Bob Ardecky, Khalid Benbatoul et al. · Proceedings of the National Academy of Sciences · 2007 · 67 citations · Full text

, , +14

2,4,5-Trisubstituted imidazoles

Chengzhi Zhang, Sepehr Sarshar, Edmund J. Moran et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 61 citations

Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast

Yen Tran, Khalid Benbatoul, Karen Gorse et al. · Oncogene · 1998 · 53 citations · Full text

, , +9

Rows per page

1–5 of 10